TBC1D9, TBC1 domain family member 9, 23158

N. diseases: 491; N. variants: 11
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1333064
Disease: Classical Hodgkin's Lymphoma
Classical Hodgkin's Lymphoma
0.010 Biomarker disease BEFREE We developed two BV-resistant HL cell line models using a pulsatile approach and observed that resistance to BV is associated with an upregulation of multidrug resistance-1 (MDR1). 31811017 2020
CUI: C2347747
Disease: Adult Classical Hodgkin Lymphoma
Adult Classical Hodgkin Lymphoma
0.010 Biomarker disease BEFREE We developed two BV-resistant HL cell line models using a pulsatile approach and observed that resistance to BV is associated with an upregulation of multidrug resistance-1 (MDR1). 31811017 2020
CUI: C3539878
Disease: Triple Negative Breast Neoplasms
Triple Negative Breast Neoplasms
0.010 Biomarker disease BEFREE This yielded robust suppression of the miR-34a target genes CCND-1, Notch-1, Bcl-2, Survivin, and MDR-1, which reduced TNBC cell proliferation and induced cell cycle arrest. 31742868 2020
CUI: C4722518
Disease: Triple-Negative Breast Carcinoma
Triple-Negative Breast Carcinoma
0.010 Biomarker disease BEFREE This yielded robust suppression of the miR-34a target genes CCND-1, Notch-1, Bcl-2, Survivin, and MDR-1, which reduced TNBC cell proliferation and induced cell cycle arrest. 31742868 2020
CUI: C0175754
Disease: Agenesis of corpus callosum
Agenesis of corpus callosum
0.010 AlteredExpression disease BEFREE MDR1 and P-gp expression were positively correlated in ACC (P<0.0001, ρ = 0.723). 30650062 2019
CUI: C0206667
Disease: Adrenal Cortical Adenoma
Adrenal Cortical Adenoma
0.010 AlteredExpression disease BEFREE MDR1 mRNA and P-gp protein expression were lower in ACCs compared to adrenocortical adenomas (P<0.0001; P<0.01, respectively). 30650062 2019
CUI: C0282160
Disease: Aplasia Cutis Congenita
Aplasia Cutis Congenita
0.010 AlteredExpression disease BEFREE MDR1 and P-gp expression were positively correlated in ACC (P<0.0001, ρ = 0.723). 30650062 2019
CUI: C0796074
Disease: MOHR-TRANEBJAERG SYNDROME
MOHR-TRANEBJAERG SYNDROME
0.010 Biomarker disease BEFREE This study aimed to investigate the role of long non-coding RNA (lncRNA) X-inactive specific transcript (XIST) and multidrug resistance-1 (MDR1) in tumor tissue samples and the chemoresistant human NSCLC cell lines, H460/DDP and A549/DDP, and in a murine A549/DDP tumor xenograft. 31659146 2019
CUI: C1609538
Disease: Latent Tuberculosis
Latent Tuberculosis
0.010 AlteredExpression disease BEFREE We discovered that M. tuberculosis infection increases the expression of macrophage MDR1 to extrude various chemical substances, including tuberculosis drugs, resulting in enhanced survival of intracellular M. tuberculosis. 31412123 2019
CUI: C0002962
Disease: Angina Pectoris
Angina Pectoris
0.010 GeneticVariation phenotype BEFREE Studies indicate that there is an increased serum concentration of amlodipine (a calcium channel blocker used to treat hypertension and angina) in patients having mutant multidrug resistance 1 (MDR1) gene. 28656587 2018
CUI: C0019196
Disease: Hepatitis C
Hepatitis C
0.010 Biomarker disease BEFREE With aforementioned results, determination of different forms of SNPs in MDR1 gene should be considered as a predictor in the treatment of all chronic HCV patients. 29155127 2018
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.010 GeneticVariation group BEFREE Studies indicate that there is an increased serum concentration of amlodipine (a calcium channel blocker used to treat hypertension and angina) in patients having mutant multidrug resistance 1 (MDR1) gene. 28656587 2018
CUI: C0079588
Disease: Ichthyosis, X-Linked
Ichthyosis, X-Linked
0.010 Biomarker disease BEFREE These results suggest that a significant mRNA level of MDR1 gene was intrinsically present in STS before exposure to chemotherapeutic drugs, suggesting that MDR1 may be important contributors of innate chemoresistance of this tumor type. 29689707 2018
CUI: C0151718
Disease: Hypocholesterolemia
Hypocholesterolemia
0.010 AlteredExpression disease BEFREE Cholesterol depletion by methyl beta cyclodextrin (MβCD) inhibited malignant ascites-induced chemoresistance to CDDP and upregulation of MDR1 and LXRɑ/β. 30526541 2018
CUI: C0162311
Disease: Androgenetic Alopecia
Androgenetic Alopecia
0.010 AlteredExpression disease BEFREE The effect of ABR on the expression levels of P-glycoprotein (P-gp) and MDR1 mRNA in the synovial tissues of knee joints in AGA rats was examined by Western blot and RT-qPCR assay, respectively. 29679725 2018
CUI: C0162557
Disease: Liver Failure, Acute
Liver Failure, Acute
0.010 Biomarker disease BEFREE MDCK-MDR1 and HCMEC/D3 cells were used to document the effects of the abnormally altered components in serum of ALF mice on the function and expression of P-GP. 29559914 2018
CUI: C0272138
Disease: Erythroblastosis
Erythroblastosis
0.010 AlteredExpression disease BEFREE The intracellular multidrug resistance 1 (MDR1) mRNA and upstream erythroblastosis virus E26 oncogene homolog 1 (ETS1) mRNA can be silenced by MBs, which can effectively inhibit the expression of P-gp and further prevent the efflux of Dox and reverse MDR. 29663807 2018
CUI: C0524910
Disease: Hepatitis C, Chronic
Hepatitis C, Chronic
0.010 GeneticVariation disease BEFREE MDR1 gene C3435T polymorphism in chronic hepatitis C patients. 29155127 2018
CUI: C0700345
Disease: Candidiasis, Vulvovaginal
Candidiasis, Vulvovaginal
0.010 GeneticVariation disease BEFREE The aim of the present study was to investigate the association between Mrr1, adenylyl cyclase-associated protein 1 (Cap1) and multi-drug resistance gene 1 (MDR1), and to assess the mutations in Mrr1 and Cap1 in azole-resistant <i>Candida albicans</i> strains.The study isolated 68 <i>C. albicans</i> strains from patients with vulvovaginal candidiasis. 29434708 2018
Steroid Sulfatase Deficiency Disease
0.010 Biomarker disease BEFREE These results suggest that a significant mRNA level of MDR1 gene was intrinsically present in STS before exposure to chemotherapeutic drugs, suggesting that MDR1 may be important contributors of innate chemoresistance of this tumor type. 29689707 2018
CUI: C0002726
Disease: Amyloidosis
Amyloidosis
0.010 Biomarker disease BEFREE The expulsion of via the blood-brain barrier is mediated by specialized transport proteins such as P-glycoprotein (P-gp, ABCB1/MDR1). 27915995 2017
Diabetes Mellitus, Non-Insulin-Dependent
0.010 Biomarker disease BEFREE In case of CYP46A1 gene, CC (p < 0.001) and CT (p = 0.001) genotypes and C allele (p < 0.001) were found to be a positive risk factor and TT genotype (p < 0.001) and T allele (p < 0.001) as negative risk factor for T2DM whereas, no association of MDR1 gene was found with T2DM (P values of all genotypes and alleles were greater than 0.001). 28206854 2017
CUI: C0019202
Disease: Hepatolenticular Degeneration
Hepatolenticular Degeneration
0.010 Biomarker disease BEFREE Our data add to the versatile functions of MDR1 in the hepatocyte and may have an impact on the treatment of copper-related diseases, prominently WD. 28805879 2017
CUI: C0020877
Disease: Ileitis
Ileitis
0.010 Biomarker disease BEFREE Blocking ileal CBA reabsorption in transferred Rag1<sup>-/-</sup> mice restored Mdr1-deficient Teff cell homeostasis and attenuated ileitis. 29262351 2017
CUI: C0079772
Disease: T-Cell Lymphoma
T-Cell Lymphoma
0.010 Biomarker disease BEFREE Effect of compound 1 on the reversion of multidrug resistant (MDR) mediated by Pglycoprotein (P-gp) against cancer cells was evaluated with a rhodamine-123 exclusion screening test on human mdr1 gene transfected mouse gene transfected L5178 and L5178Y mouse T-cell lymphoma. 28606042 2017